Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Archives of General Surgery(Electronic Edition) ›› 2020, Vol. 14 ›› Issue (01): 76-80. doi: 10.3877/cma.j.issn.1674-0793.2020.01.023

Special Issue:

• Review • Previous Articles    

Diagnosis and treatment of in-stent restenosis of lower extremity artery

Youjun Mao1, Xiaoqiang Li2,()   

  1. 1. Department of Vascular Surgery, Changzhou No.2 People’s Hospital, the Affiliated Hospital of Nanjing Medical University, Changzhou 213000, China
    2. Department of Vascular Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China
  • Received:2019-10-12 Online:2020-02-01 Published:2020-02-01
  • Contact: Xiaoqiang Li
  • About author:
    Corresponding author: Li Xiaoqiang, Email:

Abstract:

With the aging of the population, the incidence of lower extremity arterial stenosis and occlusive disease is getting higher and higher, and the endovascular stents have been widely used, thus the incidence of in-stent restenosis is also increasing. At present, the techniques used for the treatment of ISR include drug therapy, plain balloon, drug-coated balloon, bare-metal stent, drug-eluting stent, intracavity volume reduction (laser atherectomy, excisional atherectomy) and bypass surgery. The effects of single treatment methods are limited, and intracavitary volume reduction combined with drug-coated balloon can mechanically remove the proliferating intima and effectively inhibit the intimal hyperplasia, which is a reasonable method for the treatment of in-stent restenosis.

Key words: Arteriosclerosis, Femoral artery, Popliteal artery, Stents, Endovascular treatment

京ICP 备07035254号-20
Copyright © Chinese Archives of General Surgery(Electronic Edition), All Rights Reserved.
Tel: 020-87331056 E-mail: pwwxcma2007@126.com
Powered by Beijing Magtech Co. Ltd